Published in J Neurosci Methods on March 05, 2009
MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet (2012) 1.58
Morin attenuates tau hyperphosphorylation by inhibiting GSK3β. Neurobiol Dis (2011) 0.83
Reconfigurable hybrid interface for molecular marker diagnostics and in-situ reporting. Biosens Bioelectron (2015) 0.75
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron (2004) 13.99
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med (2006) 11.29
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood (2006) 7.63
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med (2012) 7.58
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell (2007) 7.10
The National Survey of American Life: a study of racial, ethnic and cultural influences on mental disorders and mental health. Int J Methods Psychiatr Res (2004) 6.99
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med (2008) 6.90
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol (2008) 6.76
A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet (2005) 5.81
Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health (2010) 5.74
Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet (2006) 5.59
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol (2010) 5.03
The social determinants of health: coming of age. Annu Rev Public Health (2011) 4.98
A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res (2010) 4.77
Cross-national epidemiology of DSM-IV major depressive episode. BMC Med (2011) 4.52
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet (2012) 4.25
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain (2002) 4.16
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem (2003) 3.79
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood (2006) 3.64
Racial and spatial relations as fundamental determinants of health in Detroit. Milbank Q (2002) 3.41
Optimal indicators of socioeconomic status for health research. Am J Public Health (2002) 3.38
Cross-national analysis of the associations among mental disorders and suicidal behavior: findings from the WHO World Mental Health Surveys. PLoS Med (2009) 3.38
Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. Br J Psychiatry (2010) 3.38
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34
Noninvasive imaging of the human rod photoreceptor mosaic using a confocal adaptive optics scanning ophthalmoscope. Biomed Opt Express (2011) 3.21
Discrimination, symptoms of depression, and self-rated health among african american women in detroit: results from a longitudinal analysis. Am J Public Health (2006) 2.97
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet (2011) 2.97
Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol (2005) 2.94
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial. Lancet (2013) 2.89
Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord (2004) 2.84
Functional photoreceptor loss revealed with adaptive optics: an alternate cause of color blindness. Proc Natl Acad Sci U S A (2004) 2.82
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurol (2009) 2.82
The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann Neurol (2003) 2.80
Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. J Clin Psychiatry (2010) 2.75
Health disparities based on socioeconomic inequities: implications for urban health care. Acad Med (2004) 2.70
Understanding social disparities in hypertension prevalence, awareness, treatment, and control: the role of neighborhood context. Soc Sci Med (2007) 2.69
Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study. Mov Disord (2003) 2.69
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain (2005) 2.67
Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain (2003) 2.63
Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann Neurol (2003) 2.61
Depression care in the United States: too little for too few. Arch Gen Psychiatry (2010) 2.57
Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol (2006) 2.56
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol (2005) 2.55
ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov Disord (2010) 2.47
Evidence for acute neurotoxicity after chemotherapy. Ann Neurol (2010) 2.45
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis (2006) 2.42
Self-reported health, perceived racial discrimination, and skin color in African Americans in the CARDIA study. Soc Sci Med (2006) 2.42
Organization of the human trichromatic cone mosaic. J Neurosci (2005) 2.42
Parkin disease: a phenotypic study of a large case series. Brain (2003) 2.41
Self-reported racial discrimination and substance use in the Coronary Artery Risk Development in Adults Study. Am J Epidemiol (2007) 2.40
Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation (2004) 2.39
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol (2009) 2.38
In vivo fluorescence imaging of primate retinal ganglion cells and retinal pigment epithelial cells. Opt Express (2006) 2.37
Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov Disord (2010) 2.36
Race, ethnicity, and the use of services for mental disorders: results from the National Survey of American Life. Arch Gen Psychiatry (2007) 2.36
The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study. Neurology (2003) 2.35
Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry (2008) 2.35
Socioeconomic status and health: the role of sleep. Psychosom Med (2002) 2.33
Stress, life events, and socioeconomic disparities in health: results from the Americans' Changing Lives Study. J Health Soc Behav (2005) 2.31
The reflectance of single cones in the living human eye. Invest Ophthalmol Vis Sci (2003) 2.27
African American girls' smoking habits and day-to-day experiences with racial discrimination. Nurs Res (2002) 2.24
Racism and cardiovascular disease in African Americans. Am J Med Sci (2003) 2.23
The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain (2004) 2.20
Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain (2010) 2.19
In vivo autofluorescence imaging of the human and macaque retinal pigment epithelial cell mosaic. Invest Ophthalmol Vis Sci (2008) 2.19
Examination of how neighborhood definition influences measurements of youths' access to tobacco retailers: a methodological note on spatial misclassification. Am J Epidemiol (2013) 2.18
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain (2003) 2.17
Neighbourhood characteristics, individual level socioeconomic factors, and depressive symptoms in young adults: the CARDIA study. J Epidemiol Community Health (2005) 2.13
High-resolution retinal imaging of cone-rod dystrophy. Ophthalmology (2006) 2.13
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain (2011) 2.13
The integral role of pastoral counseling by African-American clergy in community mental health. Psychiatr Serv (2003) 2.10
Testicular hypofunction and multiple sclerosis risk: a record-linkage study. Ann Neurol (2014) 2.09
Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol (2010) 2.08
Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann Neurol (2012) 2.08
Optical fiber properties of individual human cones. J Vis (2002) 2.06
Food insufficiency and women's mental health: findings from a 3-year panel of welfare recipients. Soc Sci Med (2005) 2.03
Identical twins with Leucine rich repeat kinase type 2 mutations discordant for Parkinson's disease. Mov Disord (2012) 2.02
The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders. S Afr Med J (2009) 1.99
Toward a policy-relevant analysis of geographic and racial/ethnic disparities in child health. Health Aff (Millwood) (2008) 1.98
Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord (2007) 1.96
The locus of fixation and the foveal cone mosaic. J Vis (2005) 1.96
Vulnerability as a function of individual and group resources in cumulative risk assessment. Environ Health Perspect (2007) 1.94
Past horrors, present struggles: the role of stigma in the association between war experiences and psychosocial adjustment among former child soldiers in Sierra Leone. Soc Sci Med (2009) 1.93
Stigma and racial/ethnic HIV disparities: moving toward resilience. Am Psychol (2013) 1.93
Adaptive optics retinal imaging reveals S-cone dystrophy in tritan color-vision deficiency. J Opt Soc Am A Opt Image Sci Vis (2007) 1.91
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem (2006) 1.91
Poverty, food insecurity, and the behavior for childhood internalizing and externalizing disorders. J Am Acad Child Adolesc Psychiatry (2010) 1.90
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain (2011) 1.89
Light-induced retinal changes observed with high-resolution autofluorescence imaging of the retinal pigment epithelium. Invest Ophthalmol Vis Sci (2008) 1.89
Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol (2007) 1.88
Cross-national analysis of the associations between traumatic events and suicidal behavior: findings from the WHO World Mental Health Surveys. PLoS One (2010) 1.86
Social determinants of psychological distress in a nationally-representative sample of South African adults. Soc Sci Med (2008) 1.83